Ropes & Gray represented Sarepta Therapeutics (NASDAQ: SRPT) in connection with its successful liability management transaction, which resulted in the company extending the maturity of a significant portion of its debt while also de-levering its balance sheet.
The transaction, which was announced in an August 20 press release and closed August 28, 2025, consisted of privately negotiated exchanges of approximately $700.0 million in aggregate principal amount of the company’s convertible senior notes due 2027 for a combination of approximately $602.0 million in aggregate principal amount of new convertible senior notes due 2030, approximately 5.9 million shares of Sarepta’s common stock and approximately $123.3 million in cash.
The Ropes & Gray team included capital markets partner Will Michener, finance partner Nitin Konchady and capital markets associates Dayna Atkins and Emily Weiss-Cook.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.